Federal 340B Drug Pricing Program; impacts within the Commonwealth.

The Virginia Legislature approved file SB278 ("Federal 340B Drug Pricing Program; impacts within the Commonwealth."), by a recorded vote of 137 to 0. Last action: April 13, 2026.

Virginia file SB278, before the Virginia Legislature. Passed as of 2026-04-13.

Official summary

Drug manufacturers; 340B Drug Pricing Program; work group; report. Directs the Secretary of Health and Human Resources to convene a work group to conduct a comprehensive evaluation of the impacts of the federal 340B Drug Pricing Program within the Commonwealth, with emphasis on governance, transparency, and the availability of pharmacy services in rural and underserved areas. The bill requires the work group to submit a report on its findings and recommendations to the Chairs of the Senate Committees on Finance and Appropriations and Education and Health and the House Committees on Appropriations and Health and Human Services by November 1, 2026.

How they voted

Yes (137)

Did not vote / other (3)

Read the official record for SB278

See everything up for a vote · This week in Virginia · See what we have filed with the clerk